MedPath

The effect of ginger on the severity and frequency of chemotherapy-induced nausea and vomiting

Phase 3
Recruiting
Conditions
Chemotherapy induced nausea and vomiting.
Adverse effect of antineoplastic and immunosuppressive drugs
T45.1X5A
Registration Number
IRCT20210505051188N1
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
44
Inclusion Criteria

Age over 18 years
Prescribing chemotherapy regimen based on doxorubicin and platinum compounds by the oncologist
Ability to swallow capsules
Having chemotherapy experience with nausea and vomiting
Presence in the ward for 24 hours to evaluate anti-nausea drugs
No history of nausea and vomiting for reasons other than chemotherapy
Not receiving anti-nausea and vomiting drugs in the last 24 hours

Exclusion Criteria

Patients who do not sign the moral consent form.
Patients who do not cooperate during treatment for any reason to continue treatment.
History of any allergy to ginger
Occurrence of nausea before chemotherapy for any reason
Having any disease that causes nausea and vomiting, such as hepatitis, gastrointestinal obstruction
Taking anticoagulants such as heparin
The presence of blood disorders such as platelets less than 10,000 per microliter.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath